ProQR Therapeutics PRQR
NASDAQ PRQR
$1.39 +0.01 (+1.09%)
As of: Oct 21, 2026 · 2:12 PM EDT

ProQR Therapeutics (PRQR) Receivables (2022 - 2026)

Updated

ProQR Therapeutics (PRQR) posted Receivables of $4.54 million for the quarter ended Jun 30, 2026, down 11.9% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Receivables (2022 - 2026) Analysis & Trends

As of Dec 31, 2025, ProQR Therapeutics' Receivables came in at $7.68 million, up 54.9% from the prior year.

  • Annual Receivables shows a three-year compound annual growth rate of -49.5% (years ended Dec 2022 to Dec 2025).
  • In prior years, ProQR Therapeutics' Receivables was $4.96 million in the year ended Dec 31, 2024 and $59.68 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,134.06 Bn 1,102.65 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn 19.05 Bn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn 13.82 Bn
4 Merck 367.24 Bn 321.62 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.48 Bn 235.17 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn 5.06 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn 12.49 Bn
10 ProQR Therapeutics 146.94 Mn -313.72 Mn - 4.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.46 Mn
Mar 31, 2026 5.05 Mn
Dec 31, 2025 7.99 Mn
Dec 31, 2024 4.77 Mn
Dec 31, 2022 60.37 Mn
API Access

ProQR Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=PRQR&period=max&api_key=YOUR_API_KEY